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Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians.
Little is known of the natural history of nephropathy in type 2
(non-insulin-dependent) diabetes, yet type 2 diabetes is a major cause of
end-stage renal disease in the United States. The incidence rate of
heavy proteinuria was determined in Pima Indians participating in a
longitudinal population study of diabetes and its complications. Heavy
proteinuria was defined by a urine protein (g/liter) to urine creatinine (g/
liter) ratio 1.0 ( 113 mg proteinlmmol creatinine), a level which
corresponds to a urine protein excretion rate of about 1 g/day. The
incidence rates of proteinuna in diabetic Pimas were 4, 12, 37, and 106
cases/I ,000 person-years at risk in the periods 0 to 5, 5 to 10, 10 to 15,
and 15 to 20 years after the diagnosis of diabetes. The cumulative
incidence rates were 2%, 8%, 23%, and 50% at 5, 10, 15, and 20 years,
respectively. The duration of diabetes, severity of diabetes as deter-
mined by the degree of hyperglycemia and type of treatment, and blood
pressure were risk factors for proteinuria. The presence of heavy
proteinuna was strongly associated with the development of renal
insufficiency, defined by serum creatinine  2.0 mg/dl ( 177 mo1I
liter). The incidence of proteinuria in type 2 diabetes in Pima Indians
was as high as that reported in type I diabetes in other populations and
represents a frequent, serious complication of the disease.
The belief that renal disease develops more frequently in type
1 (insulin-dependent) than in type 2 (non-insulin-dependent)
diabetes [1—3] is based primarily on studies in Caucasian
populations which show that 30 to 60% of deaths in type I
diabetes are attributable to renal failure [4—6], yet fewer than
5% of deaths in type 2 diabetes are attributable to this cause [7,
8]. Extensive studies of the natural history of nephropathy in
patients with type 1 diabetes have permitted characterization of
a course progressing to end-stage renal disease [9, 10]. The
natural history of nephropathy in subjects with type 2 diabetes,
however, has not been well described even though 80 to 90% of
the diabetic population in the United States has type 2 diabetes,
as do at least 50% of the diabetic patients receiving treatment
for end-stage renal disease [4]. Some reports of the course of
diabetic nephropathy have included subjects with both type 1
and type 2 diabetes [11, 121, whereas others have been limited
to those with type 1 diabetes [6, 13, 14].
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Since 1965, Pima Indians living in the Gila River Indian
Community in southern Arizona, USA have participated in a
longitudinal study of diabetes and its complications. This tribe
has the world's highest reported prevalence of diabetes (50% at
 35 years of age) [15]. Pima Indians have diabetes which is not
associated with insulin dependency, ketoacidosis, or islet-cell
antibodies, and is, therefore, type 2 diabetes [16], even when it
occurs in the young [17]. Diabetic nephropathy is the predom-
inant form of kidney disease in this population and is similar in
its clinical characteristics and classical pathologic features to
that described in other populations [18]. It frequently results in
end-stage renal disease, which develops in nearly 15 per cent of
diabetic Pima Indians by 20 years duration of diabetes [19].
The purposes of the present study were: (I) to investigate the
incidence of nephropathy as reflected by the presence of heavy
proteinuria in a population with a high prevalence and relatively
early age of onset of type 2 diabetes; (2) to compare the
incidence of proteinuria in type 2 diabetes with that reported in
type 1 diabetes; and (3) to identify possible risk factors for the
development of proteinuria in subjects with diabetes.
Methods
Since 1965, all Pima Indians at least five years of age living in
a defined area of the Gila River Indian Community in Arizona
have been asked to participate in systematic biennial research
examinations. These examinations included a modified oral
glucose tolerance test, measurements of height, weight, and
blood pressure, and collection of urine. After voiding, the
patients were given a 75 g oral carbohydrate load (Glucola,
Ames Division of Miles Laboratory Inc., Elkhart, Indiana or
Dexcola, Custom Laboratories Inc., Baltimore, Maryland,
USA). Two hours later, venous blood was drawn for plasma
glucose and serum creatinine determinations, and a urine spec-
imen was collected and screened for protein with bromphenol
strips (Labstix, Miles Laboratory Inc.). Protein concentration
was determined by the Shevky-Stafford procedure [20] on all
specimens showing a trace or more of protein; the concentra-
tion of creatinine in the same urine specimen was determined;
and the protein (g/liter) to creatinine (glliter) ratio was calcu-
lated. Heavy proteinuria was defined by a P/C ratio 1.0 (or
113 mg protein/mmol creatinine). This ratio is equivalent to a
total protein excretion rate of about 1 g per day [21, 22]. No
other means of quantifying proteinuria, such as by repeated
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Table 1. Incidencea of heavy proteinuria (P/C 1.0)
Age
years Sexb
Nondiabetic Diabetic
Person-years Cases Incidence Person-years Cases Incidence
5—24 M 10678 7 0.7 108 1 9,3
F 12594 17 1.4 264 I 3.8
25—44 M 2866 1 0.3 1208 17 14.1
F 4942 15 3.0 1580 23 14.6
45—64 M 1292 0 0.0 1116 28 25.1
F 1640 3 1.8 2421 70 28.965 M 678 3 4.4 472 10 21.2
F 520 3 5.8 710 30 42.3
Total 35210 49 7878 180
Age-sex adjusted incidence 1.7 16.5
95% confidence interval (1.1—2.4) (12.2—20.8)
Cases/l000 person-years at risk
b M = male, F = female
measurements over several months or by 24-hour urine collec-
tions, was routinely available in this large population study.
Diabetes was diagnosed at the first biennial examination at
which the two-hour post-load plasma glucose was  200 mg/dl
(11.1 mmol/liter) [23], or when the Indian Health Service
Hospital serving the community found a post-prandial or two-
hour post-load glucose concentration of  200 mg/dl (11.1
mmol/liter) [15]. Renal insufficiency was defined by a serum
creatinine concentration  2.0 mg/dl (177 j.mol/liter). Blood
pressure was measured with a mercury sphygmomanometer
with the subject resting supine. Systolic and diastolic pressures
were taken by auscultation of the brachial artery.
Incidence, the rate at which persons at risk develop protein-
uria, was expressed as the number of new cases of proteinuria
per 1000 person-years at risk. Cumulative incidence rates of
proteinuria in diabetic Pimas and in subjects from two other
longitudinal studies of diabetic nephropathy were compared
[13, 14]. Cumulative incidence rates were presented in the
studies or derived from incidence rates [24] stratified by dura-
tion of diabetes. The cumulative incidence estimates the prob-
ability that proteinuria will develop by a certain duration of
diabetes conditional on survival to that point. Sex, obesity,
two-hour plasma glucose concentration at diagnosis, blood
pressure, type of treatment, cigarette smoking, and age at
diagnosis of diabetes were examined as risk factors for protein-
uria. The effects of variables which change over time, such as
age, duration of diabetes, blood pressure, and type of treat-
ment, were assessed by stratification of person-years at risk of
proteinuria. Age was categorized and changed at each subject's
5th, 25th, 45th, or 65th birthday (that is, at 20 year intervals
starting at age 5 years, the earliest possible entry in the study);
five-year diabetes duration categories were used starting at the
date of diagnosis and changing at the 5-, 10- and 15-year
anniversaries of that date; and variables such as blood pressure
or type of treatment for diabetes, that were assessed at biennial
examinations, were changed at each subsequent examination.
Blood pressure measurements were categorized according to
the observed values whether or not antihypertensive drugs
were taken. Subjects were also stratified by factors which did
not change with time, such as sex and age and plasma glucose
at the time of diagnosis.
The incidence of renal insufficiency was computed by similar
methods. New cases of renal insufficiency were defined by the
first occurrence of a serum creatinine concentration  2.0 mg/
dl (177 .tmol/liter) at a biennial examination among persons with
at least one previous biennial examination at which the serum
creatinine concentration was below this level. Person-years at
risk were stratified by duration of diabetes as described above
and by the presence of heavy proteinuria. Proteinuria was
classified as absent or present at each biennial examination
according to whether the P/C ratio was < 1.0 or 1.0, and the
person-years at risk of renal failure were accumulated for that
category until the next biennial examination.
Incidence rates were age-sex adjusted by the direct method
using the 1980 U.S. census population as a standard, as
previously described [15]. Age-sex adjusted rates were calcu-
lated in categories of duration of diabetes and had to be
restricted to subjects  25 years of age as the longer duration
categories were not represented among younger subjects. Inci-
dence rate ratios, adjusted for age, sex, and duration of diabe-
tes, were computed by the Mantel and Haenszel procedure [25];
tests of linear association were computed by the Mantel exten-
sion test [261. These analyses were modified for person-time
denominators as suggested by Rothman and Boice [271.
Results
Among the diabetic subjects, 180 of the 480 persons at risk
developed heavy proteinuria during 7,878 person-years of fol-
low-up, and among nondiabetic subjects, 49 of 4,171 developed
heavy proteinuria during 35,210 person-years of follow-up
(Table 1). The age-sex-adjusted incidence of heavy proteinuria
was 9.7 times as high in diabetic as in nondiabetic subjects (95%
confidence interval = 6.1 to 15.3). In diabetic subjects, the
incidence of heavy proteinuria increased with increasing age
until ages 45 to 64 years in males and  65 years in females.
Among diabetic subjects, the incidence rate was similar in men
and women after adjustment for age and duration of diabetes
(incidence rate ratio, men compared with women, 1.0, 95%
confidence interval = 0.7 to 1.4). Among subjects  25 years of
age with diabetes, the age-sex adjusted incidence rate increased
from 4 cases per 1,000 person-years in those with less than 5
years duration to 106 cases per 1,000 person-years in those with
15 years duration (Fig. 1). Among all diabetic subjects, the
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cumulative incidence of heavy proteinuria as a function of
duration of diabetes was 50% after 20 years (Fig. 2).
Table 2 shows the incidence rates of heavy proteinuria in
diabetic subjects  25 yearsof age stratified by age and duration
of diabetes. The incidence rates clearly increased with longer
duration of diabetes in each age group, whereas within catego-
ties of duration of diabetes, the differences between age groups
were small. After controlling for duration of diabetes there was
no significant effect of age; whereas after controlling for age, the
effect of duration was highly significant (P < 0.001).
Table 3 shows the incidence of renal insufficiency in diabetic
subjects  25 years of age according to duration of diabetes and
presence or absence of heavy proteinuria at the previous
biennial examination. The age-sex-duration-adjusted incidence
of renal insufficiency among diabetic subjects was 42 times as
high in those with proteinuria as in those without (95% confi-
dence interval = 24 to 75). Sex had no significant effect on the
Age
years
Duration of diabetes years
0—5 5—10 10—15 >15
25—44 4.0 9.6 37.8 128.3
45-64 6.5 12.8 32.1 91.865 0.0 15.7 43.0 77.3
incidence of renal insufficiency after controlling for presence of
proteinuria, age, and duration of diabetes (incidence rate ratio,
men compared with women, =1.1, 95% confidence interval =
0.6 to 1.9).
Figure 3 shows the incidence of proteinuria according to the
duration of diabetes in relation to several risk factors: a) age at
diagnosis, b) two-hour post-load plasma glucose at diagnosis, c)
type of treatment, and d) blood pressure. Subjects with a
younger age at diagnosis of diabetes tended to have a higher
incidence rate (Fig. 3A), but the differences among the groups
shown were not statistically significant. There was a strong
association between the severity of hyperglycemia at the time
of diagnosis of diabetes and the incidence of proteinuria, (P <
0.01, controlling for age, sex, and duration of diabetes, Fig. 3B).
In each duration group, subjects with the highest two-hour
post-load plasma glucose at diagnosis ( 450 mgldl) had the
highest incidence of proteinuria. Figure 3C shows the incidence
of proteinuria according to the type of treatment: insulin, oral
hypoglycemic agents, or no drug. The incidence rate was
highest in subjects who were being treated with insulin, inter-
mediate in those treated with oral agents, and lowest in those
treated without drugs (P <0.001, controlling for age, sex, and
duration of diabetes). The incidence of proteinuria was signifi-
cantly related to systolic blood pressure (P < 0.001, controlling
for age, sex, and duration of diabetes, Fig. 3D) and to diastolic
blood pressure (data not shown). The relationship with systolic
blood pressure persisted after stratification by the simultaneous
two-hour post-load plasma glucose concentration (P < 0.001,
controlling for age, sex, duration of diabetes, and two-hour
glucose). Neither obesity, as measured by body mass index, nor
cigarette smoking was associated with an increased rate of
proteinuria (not shown).
Discussion
Because of the high frequency and relatively early age of
onset of type 2 diabetes in Pima Indians [151, it has been
possible to examine the incidence of proteinuria with fewer
problems than encountered in many studies of type 2 diabetes in
older subjects. One of these problems is the high mortality from
other causes that is encountered in many studies even at
relatively short durations of diabetes. Because of the frequent
onset of diabetes at an early age, many diabetic Pima Indians
survive long enough after diagnosis to allow proteinuria to
develop.
Among the Pimas, it has been possible to estimate the onset
of diabetes with reasonable accuracy because glucose tolerance
testing has been performed at approximately two-year intervals
since 1965. Estimating disease onset in other populations is
usually difficult in type 2 diabetes, as subjects may remain
Table 2. Incidencea of heavy proteinuria
a Incidence in cases/1000 person-years, both sexes combined, in
subjects 25 years old.
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Fig. 1. Incidence rates (and 95% confidence intervals) of heavy pro-
teinuria by duration of diabetes. Age-sex adjusted in subjects  25
years old.
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Fig. 2. Cumulative incidence of heavy proteinuria in diabetic Pima
Indians.
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Table 3. Incidencea of renal insufficiency (serum creatinine 2.O mg/dl or 177 Lmol/liter) by duration
proteinuna at the previous biennial examination
of diabetes and presence of heavy
Duration of
diabetes
years
Without proteinuria With proteinuria
Person-yr Cases Incidence Person-yr Cases Incidence
0—5
5—10
10—15
15—2020
2811
2302
1490
716
246
0 0.0 124
0 0.0 120
1 0.3 182
3 2.1 174
I 5.1 128
1
4
11
15
14
12.7
34.3
57.9
56.0
101.4
0
Duration of diabetes, years
Fig. 3. Incidence of heavy proteinuria in diabetic Pima Indians according to: (A) age at diagnosis (yrs.); (B) 2-hr post-load plasma glucose at
diagnosis (mgldl); (C) type of treatment for diabetes (insulin, oral hypoglycemic agent, or no hypoglycemic drugs); and (D) systolic blood pressure
(mm Hg).
asymptomatic for many years prior to recognition of their
disease, Furthermore, as nearly all eligible Pimas have received
systematic examinations [15], it has been possible to avoid the
problems associated with the selective referral of patients with
complications to centers specializing in diabetes care.
Heavy proteinuria in this study was defined by a urine protein
(g/liter) to urine creatinine (g/liter) ratio of 1.0, which
corresponds to a protein excretion rate of about 1 g/day [21, 22].
Persistent proteinuria, as detected by conventional clinical
methods and used as an index of nephropathy in many studies
of nephropathy in type 1 diabetes, is almost invariably present
at this level. Moreover, the relative frequency of proteinuria as
defined by a P/C ratio of  1.0 among diabetic compared with
nondiabetic subjects indicates its specificity in diabetic subjects
as an index of diabetes-related kidney disease.
The overall impact of renal disease associated with diabetes
among the Pimas is considerable. Proteinuria predicts the
development of renal insufficiency. Furthermore, end-stage
renal disease, or death from renal disease, occurs 62 times as
frequently among diabetic as among nondiabetic Pimas and
occurs in nearly 15 per cent of Pimas after 20 years of diabetes
[191. Other causes of renal disease among diabetic subjects
cannot be ruled out in all cases. However, given the present
knowledge of the relative frequency of proteinuria, renal insuf-
ficiency, end-stage renal disease [19], and postmortem appear-
ance of the kidneys in diabetic Pimas (181, it appears that
proteinuria as defined in this study is, in most instances,
attributable primarily to diabetic nephropathy.
In the present study the cumulative incidence of proteinuria
in relation to duration of type 2 diabetes in Pima Indians was as
Age-sex adjusted cases/l000 person-years in subjects 25 years old.
A
200—i
Age at Dx
0 <25
A 25—54
D 55
2-hr gluc. at Dx
o 450
4 250—449
o <250
Cl)
aa
>,
0
21.
§
150 —
100 —
50 —
0—
C
200 —
150 -
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0-
D
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Fig. 4. Cumulative incidence of heavy proteinuria among diabetic
subjects by duration of diabetes in three longitudinal studies: type 2
diabetic Pimas (0); type I diabetic subjects, Steno Memorial Hospital,
Denmark (s); and type I diabetic subjects, Joslin Clinic, USA (J).
high as that reported in type 1 diabetes. The present findings
were compared with results of two other studies (Fig. 4). In one
of these, 907 type I diabetic patients diagnosed before the age of
31 years were followed for up to 40 years at the Steno Memorial
Hospital in Denmark [13], and proteinuria was defined by
protein excretion >500 mg/24 hr in at least four successive urine
samples at least one month apart. In the other study, type 1
diabetic patients diagnosed before the age of 21 years were
followed for up to 40 years at the Joslin Clinic in Boston,
Massachusetts, USA [14], and proteinuria was defined by a
urine protein concentration of  30 mgldl in three or more
successive urine collections or 1.0 g protein in a 24-hour urine
collection. The cumulative incidence of nephropathy in type 1
diabetes in these studies was quite similar. In contrast, in the
Pimas with type 2 diabetes, the cumulative incidence up to 20
years after the diagnosis of diabetes was even higher, reaching
approximately 50% after 20 years.
These findings contrast with the common teaching that dia-
betic nephropathy is more common in type 1 than in type 2
diabetes [3, 4], a belief apparently derived from studies that
show renal failure to be a more common cause of death in type
1 than in type 2 diabetes. For example, among all deaths of
Joslin Clinic diabetic patients through 1968, the proportion
ascribed to renal disease ranged from 46% in patients who had
been diagnosed before 20 years of age (presumably with type 1
diabetes) to only 3% in those diagnosed at age 60 years or older
(presumably with type 2 diabetes) [28]. As type 2 diabetes tends
to occur at older ages, patients with type 2 diabetes are at higher
risk of death from other causes and are, therefore, less likely to
survive long enough to develop diabetic nephropathy and die as
a result of it. While renal failure as a cause of death may be
more frequent in type 1 than in type 2 diabetes, one cannot
conclude that the risk of developing nephropathy in diabetes of
a given duration is higher in type 1 diabetes. Indeed, the present
data (Fig. 4) suggest that, as a function of the duration of
diabetes, the incidence of nephropathy is at least as high in type
2 as in type 1 diabetes. Thus, the greater likelihood that death in
subjects with type 1 diabetes will be attributed to renal disease
appears to be due to their younger age, longer survival time,
and lower risk of death from other causes rather than to the type
of diabetes per Se.
Whether the rate of proteinuria among Pima Indians is typical
of that of patients of other ethnic origins with type 2 diabetes is
unknown. Careful interpopulation studies of duration-specific
incidence rates of diabetic nephropathy are necessary to re-
solve this question.
In contrast to results reported from Rochester, Minnesota
[291, in this study an older age at diagnosis of diabetes was not
associated with a higher duration-specific incidence of protein-
uria. Several other risk factors did, howeyer, predict the
development of proteinuria among diabetic Pima Indians. A
higher two-hour post-load plasma glucose at the time of the
diagnosis of diabetes predicted a higher incidence of protein-
uria, not only in the early years, but even after 15 to 20 years
duration. These findings are in accord with other studies, both
longitudinal and cross-sectional, which show an impressive
relationship between nephropathy and the degree of hypergly-
cemia [30—32]. Whether the level of hyperglycemia per se is
causally related to the development of nephropathy, or whether
it is an indicator of the severity of a more basic metabolic defect
related to diabetes, cannot be determined from the available
data.
The severity of diabetes as judged by the type of treatment
was also an important determinant of the risk of developing
proteinuria in type 2 diabetes among the Pimas, similar to the
previously reported association with the development of reti-
nopathy [33]. Such an association might arise because patients
with more severe hyperglycemia or with other complications
might be more likely to receive insulin treatment. It seems
unlikely that insulin is a causative factor for nephropathy, but,
because treatment was not randomly assigned, the present data
do not permit evaluation of this hypothesis.
Blood pressure was a risk factor for proteinuria in the present
study and may be causally related to its development. Blood
pressure was a risk factor for nephropathy in type 1 diabetes
[34], and treatment of hypertension reduced the rate of progres-
sion of nephropathy in type I diabetes [35] and decreased
albumin excretion rates in a group of patients including both
types of diabetes [36]. The present finding that blood pressure
predicts the development of proteinuria has several possible
interpretations. Blood pressure may have increased as a result
of renal disease of lesser severity than detected by the present
definition of proteinuria, and the apparent predictive value of
blood pressure for the development of heavy proteinuria may
simply reflect an effect of progression of such renal disease.
Alternatively, elevated blood pressure may result in increased
susceptibility of the kidney to diabetes-related damage. Protein-
uria may be the result of the combined insult, and blood
pressure, therefore, may be causally related to the development
of heavy proteinuria. This concept is consistent with evidence
in type 1 diabetes that parental blood pressure is predictive of
proteinuria in the offspring [37, 38] and that proteinuria is
related to increased lithium-sodium countertransport velocity
in red cells, which is thought to be a marker for idiopathic
hypertension [38, 39]. It is also consistent with the finding in the
Pima Indians that blood pressure measured prior to the devel-
opment of diabetes predicts abnormal albuminuria after the
development of diabetes [40]. Such a relationship might also
account for the familial aggregation of proteinuria and renal
10 20 30 40
Duration of diabetes, years
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insufficiency among diabetic Pimas [41]. Whether hypertension
is a consequence of early nephropathy, at a stage not detected
in the present study, or whether it is a causative factor and
present before any renal damage has occurred, remains to be
determined. Nevertheless, the possibility that the treatment of
hypertension may influence the risk and progression of
nephropathy in type 2 diabetes, as it appears to do in type 1,
clearly warrants investigation.
The incidence of proteinuria in type 2 diabetes among the
Pima Indians is at least as high as that reported in type 1
diabetes. Furthermore, some of the risk factors for proteinuria
identified in the present study, such as the duration of diabetes,
the degree of hyperglycemia, and hypertension, appear to
predict nephropathy in both types of diabetes. Whether the
incidence of nephropathy in type 2 diabetes varies between
populations is unknown, but as type 2 diabetes is by far the
most common type of diabetes and is frequently the underlying
cause of end-stage renal disease in the general population, the
natural history and determinants of nephropathy in type 2
diabetes require further elucidation.
The finding that, as a function of the duration of diabetes, the
incidence of proteinuna in type 2 diabetes is at least as high as
in type 1 diabetes is ominous in view of the much greater
frequency and apparently increasing incidence of type 2 diabe-
tes worldwide. If, in the future, more persons develop type 2
diabetes at younger ages, and mortality rates from other causes
such as ischemic heart disease decline, the burden of diabetes-
related renal disease may increase dramatically. However,
interventions, such as reduction of blood pressure, hyperglyce-
mia, or perhaps, protein intake, which may be effective in
ameliorating the course of renal disease in type 1 diabetes [42],
may also affect the course of nephropathy of type 2 diabetes.
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